About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2013 (2013), Article ID 560857, 12 pages
http://dx.doi.org/10.1155/2013/560857
Research Article

Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent

1Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 217 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
2Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
3Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
4Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15213, USA
5Tobago Health Studies Office, Scarborough, Tobago, Trinidad and Tobago
6Cancer Prevention Institute of California, Fremont, CA 94538, USA
7Department of Health Research and Policy, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA 94305, USA
8Department of Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
9The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK
10Stellenbosch University and Tygerberg Hospital, Cape Town 7505, South Africa
11Fox Chase Cancer Center, Philadelphia, PA 19111, USA
12Hôpital Général de Grand Yoff, Université Cheikh Anta Diop de Dakar, Dakar, Senegal
13Department of Preventive Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
14School of Medicine and Sylvester Cancer Center, University of Miami Miller, Miami, FL 33442, USA
15The Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD 21287, USA
16Department of Surgery, Brigham and Women’s Hospital, Boston, MA 02138, USA
17Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA
18Guyana Cancer Registry, Ministry of Health, Queenstown, Guyana
19Department of Urology and the Cancer, Therapy and Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, San Antonio, TX 78229, USA
20Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI 48202, USA
21School of Medicine, University of Benin, Benin City, Nigeria
22National Human Genome Research Institute, Bethesda, MD 20892, USA
23Department of Cancer Epidemiology and Center for Equal Health, Moffitt Cancer Center, Tampa, FL 33612, USA
24School of Clinical Medicine and Research, University of the West Indies, Nassau, Bahamas
25Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
26Department of Epidemiology, MD Anderson Cancer Center, Houston, TX 77030, USA
27Departments of Epidemiology and Biostatistics and Urology, Institute for Human Genetics, University of California, San Francisco, CA 94122, USA
28Wake Forest University, Winston-Salem, NC 27157, USA
29Korle Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana

Received 17 March 2012; Accepted 8 October 2012

Academic Editor: Folakemi Odedina

Copyright © 2013 Timothy R. Rebbeck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Boyle and B. Levin, World Cancer Report 2008, IARC Press, Lyon, France, 2008.
  2. F. T. Odedina, T. O. Akinremi, F. Chinegwundoh et al., “Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa,” Infectious Agents and Cancer, vol. 4, supplement 1, article S2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Ferlay, H. R. Shin, F. Bray, et al., “GLOBOCAN 2008,” Cancer Incidence and Mortality Worldwide: IARC CancerBase 10, International Agency for Research on Cancer, Lyon, France, 2010.
  5. D. Parkin, S. L. Whelan, J. Ferlay, et al., Cancer in Africa: Epidemiology and Prevention, IARC Press, Lyon, France, 2003.
  6. D. N. Osegbe, “Prostate cancer in Nigerians: facts and nonfacts,” Journal of Urology, vol. 157, no. 4, pp. 1340–1343, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Jackson, J. Kovi, M. Y. Heshmat et al., “Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC,” The Prostate, vol. 1, no. 2, pp. 185–205, 1980. View at Scopus
  8. S. M. Gueye, C. M. Zeigler-Johnson, T. Friebel et al., “Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men,” Urology, vol. 61, no. 5, pp. 987–992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Ukoli, U. Osime, F. Akereyeni, O. Okunzuwa, R. Kittles, and L. Adams-Campbell, “Prevalence of elevated serum prostate-specific antigen in rural Nigeria,” International Journal of Urology, vol. 10, no. 6, pp. 315–322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. M. Abbiyesuku, O. B. Shittu, O. O. Oduwole, and B. O. Osotimehin, “Prostate specific antigen in the Nigerian African,” African Journal of Medicine and Medical Sciences, vol. 29, no. 2, pp. 97–100, 2000. View at Scopus
  11. A. A. Ajape, A. Babata, and O. O. Abiola, “Knowledge of prostate cancer screening among native African urban population in Nigeria,” Nigerian Quarterly Journal of Hospital Medicine, vol. 19, no. 3, pp. 145–147, 2009. View at Scopus
  12. D. Iya, S. Chanchani, J. Belmonte, D. Morris, R. H. Glew, and D. J. A. van der Jagt, “Prostate specific antigen in Africans: a study in Nigerian men,” Nigerian Journal of Surgical Research, vol. 5, no. 3, pp. 114–119, 2003.
  13. C. A. Okolo, O. M. Akinosun, O. B. Shittu, et al., “Correlation of serum PSA and gleason score in nigerian men with prostate cancer,” African Journal of Urology, vol. 14, no. 1, pp. 15–22, 2008.
  14. B. Mutetwa, E. Taioli, A. Attong-Rogers, P. Layne, V. Roach, and C. Ragin, “Prostate cancer characteristics and survival in males of african ancestry according to place of birth: data from Brooklyn-New York, Guyana, Tobago and Trinidad,” Prostate, vol. 70, no. 10, pp. 1102–1109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Surveillance and End Results (SEER) Program, SEERStat Database: Incidence-SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (2000–2008), Linked To County Attributes-Total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch: Bethesda, MD.
  16. E. Surveillance and End Results (SEER) Program, SEERStat Database: Mortality-All COD, Aggregated With State, Total U.S. (1990–2007), 2010, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch: Bethesda, MD.
  17. S.R. Program, SEERStat software http://www.seer.cancer.gov/seerstat/, 2011, National Cancer Institute: Bethesda, MD.
  18. E. Surveillance and End Results (SEER) Program, SEERStat Database: Incidence-SEER 13 Regs Research Data, Nov 2010 Sub (1992–2008)- Linked To County Attributes-Total U.S., 1969–2009 Counties, 2011, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch: Bethesda, MD.
  19. X. Liu, S. J. Plummer, N. L. Nock, G. Casey, and J. S. Witte, “Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha,” American Journal of Epidemiology, vol. 164, no. 10, pp. 984–989, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Stanford, K. G. Wicklund, B. McKnight, J. R. Daling, and M. K. Brawer, “Vasectomy and risk of prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 10, pp. 881–886, 1999. View at Scopus
  21. I. Agalliu, C. A. Salinas, P. D. Hansten, E. A. Ostrander, and J. L. Stanford, “Statin use and risk of prostate cancer: results from a population-based epidemiologic study,” American Journal of Epidemiology, vol. 168, no. 3, pp. 250–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. V. N. Giri, J. Beebe-Dimmer, M. Buyyounouski et al., “Prostate cancer risk assessment program: a 10-Year update of cancer detection,” Journal of Urology, vol. 178, no. 5, pp. 1920–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. A. Cooney, M. S. Strawderman, K. J. Wojno et al., “Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men,” Urology, vol. 57, no. 1, pp. 91–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. G. Heeringa, K. H. Alcser, K. Doerr et al., “Potential selection bias in a community-based study of PSA levels in African-American men,” Journal of Clinical Epidemiology, vol. 54, no. 2, pp. 142–148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. B. A. Rybicki, C. Neslund-Dudas, N. L. Nock et al., “Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism,” Cancer Detection and Prevention, vol. 30, no. 5, pp. 412–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. G. Schwartz, E. M. John, G. Rowland, and S. A. Ingles, “Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor,” Cancer Biology and Therapy, vol. 9, no. 12, pp. 994–999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. L. Benford, T. T. VanCleave, N. A. Lavender, R. A. Kittles, and L. R. Kidd, “8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study,” BMC Cancer, vol. 10, article 334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Strom, Y. Yamamura, F. N. Flores-Sandoval, C. A. Pettaway, and D. S. Lopez, “Prostate cancer in Mexican-Americans: identification of risk factors,” Prostate, vol. 68, no. 5, pp. 563–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. N. Kolonel, B. E. Henderson, J. H. Hankin et al., “A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics,” American Journal of Epidemiology, vol. 151, no. 4, pp. 346–357, 2000. View at Scopus
  30. J. Y. Park, J. P. Tanner, T. A. Sellers et al., “Association Between Polymorphisms in HSD3B1 and UGT2B17 and Prostate Cancer Risk,” Urology, vol. 70, no. 2, pp. 374–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. R. Rebbeck, J. M. Jaffe, A. H. Walker, et al., “Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. [see comment][erratum appears in J Natl Cancer Inst 1999 Jun 16,91(12):1082],” Journal of the National Cancer Institute, vol. 90, no. 16, pp. 1225–1229, 1998.
  32. J. Beuten, J. A. L. Gelfond, J. L. Franke et al., “Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 6, pp. 1869–1880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Beuten, J. A. L. Gelfond, M. L. Martinez-Fierro et al., “Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men,” Carcinogenesis, vol. 30, no. 8, pp. 1372–1379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. E. M. John, G. G. Schwartz, J. Koo, D. van den Berg, and S. A. Ingles, “Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer,” Cancer Research, vol. 65, no. 12, pp. 5470–5479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Xu, A. S. Kibel, J. J. Hu, et al., “Prostate cancer risk associated loci in African Americans,” Cancer Epidemiol Biomarkers Preventation, vol. 18, no. 7, pp. 2145–2149, 2009. View at Publisher · View at Google Scholar
  36. M. Jalloh, C. Zeigler-Johnson, M. Sylla-Niang et al., “A study of PSA values in an unselected sample of Senegalese men,” The Canadian journal of urology, vol. 15, no. 1, pp. 3883–3885, 2008. View at Scopus
  37. A. P. Chokkalingam, E. D. Yeboah, A. Demarzo, et al., “Prevalence of BPH and lower urinary tract symptoms in West Africans,” Prostate Cancer Prostatic Diseases, vol. 15, no. 2, pp. 170–176, 2012.
  38. P. Fernandez, P. M. de Beer, L. van der Merwe, and C. F. Heyns, “COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men,” Carcinogenesis, vol. 29, no. 12, pp. 2347–2350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. H. Bunker, A. L. Patrick, B. R. Konety et al., “High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago prostate cancer survey,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 8, pp. 726–729, 2002. View at Scopus
  40. K. C. M. Coard and D. H. A. Skeete, “A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the university hospital of the West Indies, Jamaica,” British Journal of Urology International, vol. 103, no. 11, pp. 1482–1486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. E. Shirley, C. T. Escoffery, L. A. Sargeant, and T. Tulloch, “Clinicopathological features of prostate cancer in Jamaican men,” British Journal of Urology International, vol. 89, no. 4, pp. 390–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. World Health Organization, WHO World Health Statistics 2010, http://www.who.int/whosis/whostat/EN_WHS10_Full.pdf), 2010.
  43. Center for Medicare Medicaid Services, http://www.cms.gov, 2010.
  44. A. A. Phillips, J. S. Jacobson, C. Magai, N. Consedine, N. C. Horowicz-Mehler, and A. I. Neugut, “Cancer incidence and mortality in the Caribbean,” Cancer Investigation, vol. 25, no. 6, pp. 476–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. W. J. Catalona, P. C. Southwick, K. M. Slawin et al., “Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging,” Urology, vol. 56, no. 2, pp. 255–260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. P. D. Baade, D. R. Youlden, and L. J. Krnjacki, “International epidemiology of prostate cancer: geographical distribution and secular trends,” Molecular Nutrition and Food Research, vol. 53, no. 2, pp. 171–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Etzioni, D. F. Penson, J. M. Legler et al., “Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends,” Journal of the National Cancer Institute, vol. 94, no. 13, pp. 981–990, 2002. View at Scopus
  48. B. L. Chang, E. Spangler, S. Gallagher, et al., “Validation of genome-wide prostate cancer associations in men of African descent,” Cancer Epidemiol Biomarkers Preventation, vol. 20, no. 1, pp. 23–32, 2011.
  49. C. A. Haiman, G. K. Chen, W. J. Blot, et al., “Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21,” Nature Genetics, vol. 43, no. 6, pp. 570–573, 2011.
  50. C. A. Haiman, G. K. Chen, W. J. Blot et al., “Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans,” PLoS Genetics, vol. 7, no. 5, Article ID e1001387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. D. M. Parkin, H. Wabinga, and S. Nambooze, “Completeness in an African cancer registry,” Cancer Causes and Control, vol. 12, no. 2, pp. 147–152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Ferlay, D. Forman, C. D. Mathers, et al., “Breast and cervical cancer in 187 countries between 1980 and 2010,” The Lancet, vol. 379, no. 9824, pp. 1390–1391, 2012.